
https://www.science.org/content/blog-post/doubleplusgood-corporatespeak
# Article Title (September 2015)

## 1. SUMMARY

The article criticizes Bristol Myers Squibb's corporate communication strategy during the closure of their Wallingford, CT facility in June 2015. The author describes how employees faced prolonged uncertainty about their job status, learning only whether they would be allowed to re-apply for positions at BMS's Boston or New Jersey sites, rather than receiving direct job offers. The central objection is the company's euphemistic branding of these mandatory meetings as "Discovery Evolution Interviews"—a term the author finds manipulative and unhelpful. The piece highlights the anxiety and opacity surrounding corporate restructuring and layoffs, calling out the disconnect between sanitized HR language and the real-world impact on employees.

## 2. HISTORY

After the Wallingford site closure was announced in June 2015, BMS continued consolidating its R&D operations, shifting investment toward Cambridge, Massachusetts (Boston area) and its established hubs in New Jersey. This move was part of a broader strategic realignment to concentrate research assets in recognized biopharma clusters. Many Wallingford employees ultimately transitioned out of BMS or accepted roles in other locations.

The trend of site rationalization accelerated across big pharma during 2015–2020. Merck, Pfizer, Novartis, and others closed or downsized legacy facilities while expanding "innovation hubs" in Cambridge, San Francisco, and other talent- and VC-rich areas. 

BMS's restructuring coincided with its major immunotherapy push, including the continued rollout and label expansions of Opdivo (nivolumab). Both Opdivo and Yervoy (ipilimumab) became standard-of-care in oncology over the following years, and the company's strategic refocusing paid off financially. However, the human-resources fallout illustrates the recurring tension between corporate efficiency narratives and workplace stability in an industry shaped by mergers, pipeline pivots, and regional clustering.

## 3. PREDICTIONS

The article contained no explicit predictions. It used the Wallingford closure as a lens for critiquing corporate-speak and restructuring practices, but did not forecast specific outcomes for BMS's science, pipeline, employees, or competitors.

## 4. INTEREST 

Rating: **3/10**

While the article captures a genuine frustration about corporate communication during restructuring, it is primarily a critique of HR euphemisms and offers limited insight on scientific or strategic trends beyond the immediate event. The underlying themes—regional consolidation into biopharma hubs and the gap between management language and employee experience—are real, but the piece has a narrow, time-bound scope and does not deeply explore broader industry dynamics.


----
_model_params = {'model': 'nex-agi/deepseek-v3.1-nex-n1:free', 'input': '20150911-doubleplusgood-corporatespeak.txt', 'reasoning': {'effort': 'high'}, 'text': {'verbosity': 'medium'}, 'prompt-template': 'prompt-template-2'}_